This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Serous carcinoma of ovary
C3_OVARY_SEROUS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly females |
313377 |
2. Check conditionsNone |
313377 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
277 |
4. Check minimum number of eventsNone |
277 |
5. Include endpointsNone |
277 |
6. Filter based on genotype QC (FinnGen only) |
236 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Serous carcinoma of ovary
based on the number of shared cases.
Similar with more cases:
- Serous carcinoma of ovary, including Hilmo
- Malignant neoplasm of ovary
- Malignant neoplasm of ovary, including Hilmo
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, including Hilmo
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 236 | 236 | - |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | - |
| Median age at first event (years) | 59.93 | 59.93 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 245
- Matched controls
- 2450
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
+∞
307.7
245
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
244.7
192
*
H02AB02
ATC
dexamethasone; systemic
110.1
188.5
99
15
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
156.6
133
*
A04AA01
ATC
ondansetron; systemic, rectal
44.1
156.2
102
39
128
Kela drug reimbursment
Cancers of female genital organs
+∞
137.9
119
*
A03FA01
ATC
metoclopramide; systemic, rectal
17.2
117.8
159
238
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
79.6
72
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
26.6
76.5
56
27
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
76.1
69
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
16.3
68.7
65
53
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
25.3
66.2
49
24
JN4BD
NOMESCO Finland
Extensive body CT
15.2
65.7
65
57
JAL30
NOMESCO Finland
Omentectomy
112.0
62.6
66
8
L03AA02
ATC
filgrastim; parenteral
+∞
57.6
53
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
16.3
54.5
50
38
L03AA13
ATC
pegfilgrastim; parenteral
604.7
51.4
49
*
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
+∞
48.6
45
*
JEA00
NOMESCO Finland
Appendectomy
14.0
48.0
48
42
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
485.3
42.5
41
*
A04AA02
ATC
granisetron; systemic, transdermal
471.1
41.4
40
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
39.7
37
*
A04AA03
ATC
tropisetron; systemic
+∞
38.6
36
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
11.8
36.4
40
40
ZX120
NOMESCO Finland
Intravenous
8.7
35.8
51
72
L02BG04
ATC
letrozole; oral
209.9
35.8
36
*
R18
ICD-10 Finland
Ascites
54.4
35.0
41
9
Z51.5
ICD-10 Finland
Palliative care
8.5
33.5
48
68
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
33.1
31
*
LCD00
NOMESCO Finland
Hysterectomy
8.2
32.3
48
71
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
32.0
30
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
32.0
30
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
355.9
31.6
31
*
L02BA01
ATC
tamoxifen; oral
+∞
29.8
28
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
28.7
27
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
8.1
28.5
42
61
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
26.5
25
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.1
25.8
66
165
JAH01
NOMESCO Finland
Laparoscopy
9.4
24.6
31
37
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
24.4
23
*
A98
ICPC
Health maint/preventive medicine
0.2
23.9
157
2160
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
21.1
20
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
21.1
20
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.9
20.9
53
130
JAH00
NOMESCO Finland
Laparotomy
18.5
20.3
31
19
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
20.1
19
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
20.1
19
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
18.8
19.7
30
18
WX302
NOMESCO Finland
Thoracal epidural anesthesy
16.7
19.5
31
21
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
4.5
18.8
54
146
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
36.0
18.3
23
7
JN4AD
NOMESCO Finland
Body CT examination
5.5
18.2
39
82
115
Kela drug reimbursment
Breast cancer
+∞
16.9
16
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
16.9
16
*
B01AB05
ATC
enoxaparin; parenteral
3.1
16.6
119
576
HA1AA
NOMESCO Finland
X-ray mammography
5.8
16.3
32
62
WW500
NOMESCO Finland
Blood transfusion
14.3
16.1
27
21
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
15.8
15
*
130
Kela drug reimbursment
Malignant tumour
+∞
15.8
15
*
8102
FHL
Second look"" surgery for a malignant tumor
+∞
15.8
15
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.6
15.5
26
43
Z31.5
ICD-10 Finland
Genetic counselling
12.0
15.4
28
26
ZXE20
NOMESCO Finland
More than three and less than five hours
3.9
15.4
53
162
121
Kela drug reimbursment
Severe hypofunction of sexual glands
13.1
14.4
25
21
L01CB01
ATC
etoposide; systemic
+∞
13.7
13
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
13.7
13
*
TJA10
NOMESCO Finland
Laparocentesis
147.9
13.6
14
*
N02AA05
ATC
oxycodone; systemic
3.0
13.2
78
332
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.1
13.2
24
43
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.7
12.9
105
528
WZC00
NOMESCO Finland
Treatment plan or consultation
2.8
12.9
93
440
C567, ,
ICD-10 Finland
+∞
12.6
12
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
12.6
12
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
12.6
12
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
12.6
12
*
A04AD12
ATC
aprepitant; systemic
+∞
12.6
12
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.3
12.5
22
38
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
11.4
12.0
22
21
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
49.2
12.0
14
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.6
11.8
44
141
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
11.5
11
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
11.5
11
*
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
11.5
11
*
1XC07, ,
NOMESCO Finland
+∞
11.5
11
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
11.5
11
*
TLE30
NOMESCO Finland
Tamponation of vagina
+∞
11.5
11
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.8
11.0
19
16
JAL00
NOMESCO Finland
Biopsy of peritoneum
45.5
11.0
13
*
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
16.5
11.0
17
11
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
12.0
10.8
19
17
B01AB10
ATC
tinzaparin; parenteral
3.4
10.5
41
135
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
114.7
10.5
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
114.7
10.5
11
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.5
10
*
X77
ICPC
Malignant neopl genital female other
+∞
10.5
10
*
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
10.5
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.5
10
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.8
10.2
20
22
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
57.3
9.7
11
*
HAC20
NOMESCO Finland
Total mastectomy
103.9
9.5
10
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
9.4
9
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
9.4
9
*
I10
ICD-10 Finland
Essential (primary) hypertension
0.4
9.2
111
1605
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
8.9
45
173
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
51.9
8.7
10
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
28.7
8.6
11
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
93.1
8.5
9
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
93.1
8.5
9
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
93.1
8.5
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
8.4
8
*
3009
Kela drug reimbursment
Niraparib
+∞
8.4
8
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
+∞
8.4
8
*
1510
Kela drug reimbursment
Niraparib
+∞
8.4
8
*
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
8.4
8
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
22.9
8.1
11
5
HAB40
NOMESCO Finland
Wedge excision of mammary gland
22.9
8.1
11
5
N05AB04
ATC
prochlorperazine; systemic, rectal
4.7
8.0
19
43
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
13.6
8.0
13
10
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
15.7
7.8
12
8
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
82.5
7.5
8
*
J94.8
ICD-10 Finland
Other specified pleural conditions
11.4
7.4
13
12
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
7.3
101
609
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
7.3
7
*
ZX121
NOMESCO Finland
Central venous catheter
+∞
7.3
7
*
L01XK02
ATC
niraparib; oral
+∞
7.3
7
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
16.4
7.3
11
7
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
20.8
7.2
10
5
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.2
7.1
18
31
RS220, ,
NOMESCO Finland
14.3
7.0
11
8
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.3
6.7
14
473
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
71.6
6.5
7
*
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
71.6
6.5
7
*
LAE20
NOMESCO Finland
Bilateral oophorectomy
71.6
6.5
7
*
B01AB04
ATC
dalteparin; parenteral
3.7
6.4
21
61
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
6.3
6
*
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
+∞
6.3
6
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.4
6.1
11
11
Z2446
NOMESCO Finland
Social worker
3.3
6.1
23
74
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
135
2066
0.23
28.32
5.9
6.0
6.14
5.99
mmol/l
0.42
118
1851
135
2063
0.23
27.96
6.1
6.7
2.64
2.63
mmol/l
0.03
119
1871
128
2019
0.23
27.91
5.5
5.7
4.66
4.66
mmol/l
0.00
112
1827
126
1999
0.24
27.14
5.5
5.6
1.58
1.60
mmol/l
0.33
109
1803
126
1994
0.24
26.61
6.9
7.4
39.65
40.06
mmol/mol
0.27
109
1838
134
2007
0.27
22.69
7.7
6.6
2.09
2.00
mu/l
0.25
119
1834
122
1907
0.28
21.20
4.6
4.8
1.41
1.23
mmol/l
2.54
104
1698
158
2132
0.27
19.92
18.2
11.3
23.86
21.48
u/l
1.21
153
2040
120
1768
0.37
13.13
6.6
5.1
15.31
15.18
pmol/l
0.24
107
1603
40
128
3.54
10.72
3.6
1.3
9.63
2.72
ug/l
0.74
35
100
158
2017
0.39
10.56
22.3
16.4
31.87
21.78
mg/l
2.24
140
1632
71
1165
0.45
7.41
2.5
2.3
102.65
100.21
pmol/l
0.18
31
551
119
1623
0.48
7.29
4.8
5.1
16.63
14.29
mm/h
0.69
108
1497
44
800
0.45
5.49
2.1
1.8
25.53
21.58
nmol/l
0.60
38
676
61
980
0.50
5.29
4.1
3.1
109.45
97.88
ug/l
0.25
53
893
76
1133
0.52
5.17
2.5
2.6
82.10
82.39
nmol/l
0.03
69
1000
54
896
0.49
5.10
2.0
2.0
1.42
1.26
mmol/l
0.69
39
740
16
48
3.50
4.69
1.1
1.5
—
—
—
0
0
92
1206
0.62
3.20
4.7
3.0
72.73
43.70
u/l
1.03
85
1105
62
888
0.60
3.09
2.8
3.2
917.10
1408.23
ng/l
1.41
53
763
61
875
0.60
3.05
3.5
3.9
2.68
5.06
mg/mmol
1.15
31
518
130
1557
0.65
2.81
5.7
6.0
5728.80
6651.70
e6/l
—
5
23
34
553
0.55
2.66
1.6
1.8
409.15
13730469.19
pmol/l
0.50
27
437
99
1245
0.66
2.63
7.1
5.7
1.22
1.23
mmol/l
0.56
84
1084
77
1017
0.65
2.56
2.2
2.5
—
—
—
0
0
6
11
5.56
2.56
1.0
1.3
435.00
113.73
u/l
—
6
11
6
12
5.09
2.41
1.5
2.0
1.80
4.76
nmol/l
—
6
12
20
372
0.50
2.40
3.6
3.3
2.93
4.02
e6/l
—
9
172
24
418
0.53
2.34
3.3
3.1
0.85
1.83
e6/l
1.23
13
219
31
497
0.57
2.27
1.9
1.8
1118.64
1207.91
nmol/l
0.22
22
370
112
1345
0.69
2.14
5.0
4.3
6.61
6.67
mmol/l
0.19
107
1261
77
985
0.68
2.05
3.6
4.3
17.86
123.21
ng/l
0.94
61
764
103
1245
0.70
1.97
5.4
4.8
0.00
0.02
estimate
0.69
30
258
14
270
0.49
1.87
1.4
1.4
—
—
—
0
0
102
1224
0.71
1.81
5.3
4.8
0.00
0.00
estimate
-0.00
30
254
11
47
2.40
1.80
4.9
1.7
588.55
14.65
u/ml
0.47
11
40
104
1242
0.72
1.78
5.2
4.8
0.00
0.00
estimate
-0.00
28
268
32
207
1.63
1.67
2.6
1.6
63.04
67.01
g/l
1.63
26
186
7
26
2.74
1.59
1.0
1.3
—
—
—
0
0
12
57
2.16
1.58
1.5
3.4
—
—
—
0
0
92
1106
0.73
1.57
6.5
5.3
1.21
1.22
mmol/l
0.40
84
1002
8
33
2.47
1.55
1.4
1.4
—
—
—
0
0
49
652
0.69
1.53
3.5
3.5
0.29
0.54
e6/l
1.28
38
495
34
485
0.65
1.51
3.4
4.8
37.22
139.29
ng/l
1.27
26
407
50
643
0.72
1.26
2.7
2.4
2.94
2.94
mg/l
0.01
41
544
37
500
0.69
1.24
1.4
1.3
0.59
1.42
u/ml
1.11
12
124
0
35
0.00
1.16
0.0
1.3
—
—
—
0
0
7
31
2.29
1.11
1.0
1.2
—
—
—
0
0
149
1628
0.78
1.05
10.2
5.8
95.02
77.59
u/l
1.64
144
1502
9
158
0.55
1.02
1.8
1.9
—
—
—
0
0
12
68
1.80
1.02
3.2
3.8
0.71
1.04
index
—
7
27
78
905
0.80
0.88
5.7
4.8
0.04
0.05
estimate
0.06
24
199
6
32
1.90
0.82
1.0
1.2
—
—
—
0
0
47
573
0.78
0.80
4.9
4.9
1.02
1.02
kg/l
1.40
33
375
0
26
0.00
0.79
0.0
1.3
—
—
—
0
0
16
231
0.67
0.78
1.6
1.8
687.38
379.58
nmol/l
1.38
16
215
34
428
0.76
0.74
1.3
1.3
46.10
49.57
iu/ml
—
10
130
5
26
1.94
0.71
1.0
1.2
—
—
—
0
0
5
26
1.94
0.71
1.0
1.2
—
—
—
0
0
23
303
0.73
0.68
10.9
7.8
—
—
—
0
0
15
213
0.68
0.68
1.9
2.5
4.10
4.31
kpa
0.27
15
207
32
400
0.77
0.67
1.3
1.3
6.77
15.30
u/ml
0.88
12
130
52
610
0.81
0.63
4.9
4.3
0.00
0.00
estimate
-0.00
25
196
39
472
0.79
0.63
1.5
1.6
1.22
1.16
mg/l
0.07
29
367
5
30
1.68
0.62
1.0
1.2
—
—
—
0
0
8
51
1.59
0.61
1.0
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
612.09
—
0
11
0
20
0.00
0.60
0.0
1.1
—
49.57
—
0
12
0
21
0.00
0.60
0.0
4.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
45
532
0.81
0.59
3.3
2.3
329.73
334.78
umol/l
0.13
37
441
19
250
0.74
0.57
2.8
2.9
5.70
5.90
kpa
0.35
19
243
6
37
1.64
0.56
1.0
1.2
—
—
—
0
0
31
377
0.80
0.53
1.4
1.4
—
—
—
0
0
72
805
0.85
0.52
2.9
3.6
—
—
—
0
0
13
177
0.72
0.49
1.5
1.4
—
—
—
0
0
79
711
1.16
0.49
2.2
2.2
46.73
61.37
u/l
2.74
73
647
7
47
1.50
0.48
4.3
4.4
33.43
30.71
mg/l
—
7
32
7
49
1.44
0.46
1.0
1.1
—
—
—
0
0
6
91
0.65
0.43
1.3
1.2
—
—
—
0
0
6
92
0.64
0.43
1.8
1.6
1.68
0.50
g/l
—
6
78
28
232
1.23
0.42
3.9
3.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.6
—
1.04
—
0
9
0
16
0.00
0.41
0.0
1.6
—
0.91
—
0
9
0
16
0.00
0.41
0.0
1.6
—
1.18
—
0
9
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
8
113
0.70
0.38
2.0
1.5
3.40
3.75
g/l
—
8
100
8
113
0.70
0.38
2.0
1.5
7.29
7.73
g/l
—
8
100
8
113
0.70
0.38
2.0
1.5
4.21
4.45
g/l
—
8
100
16
201
0.78
0.37
2.5
2.2
30.81
30.03
u/l
0.10
16
159
9
125
0.71
0.36
1.7
2.8
24.24
25.62
mmol/l
—
9
119
8
63
1.28
0.28
1.0
1.3
—
—
—
0
0
15
122
1.24
0.27
1.7
1.5
—
—
—
0
0
117
1116
1.09
0.26
17.4
6.1
4.03
4.28
e9/l
0.70
109
948
6
84
0.71
0.24
1.3
1.5
0.97
1.63
ug/l
—
6
73
7
92
0.75
0.23
1.1
1.3
—
3.56
—
0
23
7
95
0.73
0.22
1.1
1.3
—
29.48
—
0
5
89
937
0.92
0.22
2.9
2.4
—
—
estimate
—
0
0
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
8
101
0.79
0.21
2.0
1.5
3.21
3.03
g/l
—
8
88
8
103
0.77
0.21
2.0
1.5
8.49
10.33
g/l
—
8
89
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
3.8
—
201.50
—
0
10
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
37
406
0.90
0.21
1.8
1.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
0.52
—
0
7
0
12
0.00
0.21
0.0
2.3
—
1731.33
—
0
12
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
2.8
—
—
—
0
0
10
121
0.82
0.18
1.9
1.2
220.56
189.45
u/ml
—
10
114
7
59
1.19
0.18
1.4
1.3
—
—
—
0
0
12
141
0.84
0.17
1.5
2.4
1.39
1.16
%
0.66
12
141
12
141
0.84
0.17
1.4
2.4
0.64
0.61
%
0.17
12
141
18
158
1.15
0.16
4.3
2.7
55.00
61.34
ml/min/173m2
—
9
65
6
79
0.75
0.15
1.8
1.6
0.00
0.00
g/l
—
6
73
6
79
0.75
0.15
1.8
1.6
0.00
0.00
g/l
—
6
73
9
81
1.12
0.15
1.4
1.2
—
—
—
0
0
9
110
0.81
0.13
1.0
1.0
—
—
—
0
0
18
198
0.90
0.11
1.8
2.5
0.81
0.34
e6/l
0.43
18
181
52
500
1.05
0.08
2.6
1.9
—
—
—
0
0
5
62
0.80
0.08
1.6
1.7
—
—
—
0
0
8
76
1.05
0.07
1.1
1.2
—
—
—
0
0
8
76
1.05
0.07
1.1
1.2
—
—
—
0
0
7
82
0.85
0.07
1.1
1.2
—
3.37
—
0
7
9
100
0.90
0.06
1.1
1.3
—
—
—
0
0
10
91
1.10
0.04
1.7
1.9
159.50
2419.79
ug/l
—
10
85
16
170
0.94
0.04
1.6
1.6
—
—
—
0
0
28
288
0.97
0.02
1.8
1.9
—
—
—
0
0
105
1042
1.01
0.01
5.5
3.7
32.82
35.35
g/l
3.42
97
954
70
701
1.00
0.00
5.8
4.7
0.00
0.00
estimate
-0.00
26
231
31
306
1.01
0.00
1.8
1.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
127.67
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
40.82
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
50.24
—
0
8
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.4
—
1.17
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
66
0.91
-0.00
3.2
3.5
29.63
25.45
mmol/l
—
6
66
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
-0.00
1.2
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
10.62
—
0
9
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
12.00
—
0
7
0
5
0.00
-0.00
0.0
1.4
—
7.58
—
0
5
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_OVARY_SEROUS – Serous carcinoma of ovary
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).